首页    期刊浏览 2024年11月25日 星期一
登录注册

文章基本信息

  • 标题:Nicotinic Receptor-Mediated Neuroprotection in Neurodegenerative Disease Models
  • 本地全文:下载
  • 作者:Shun Shimohama
  • 期刊名称:Biological and Pharmaceutical Bulletin
  • 印刷版ISSN:0918-6158
  • 电子版ISSN:1347-5215
  • 出版年度:2009
  • 卷号:32
  • 期号:3
  • 页码:332-336
  • DOI:10.1248/bpb.32.332
  • 出版社:The Pharmaceutical Society of Japan
  • 摘要:Multiple lines of evidence, from molecular and cellular to epidemiological, have implicated nicotinic transmission in the pathology of Alzheimer's disease (AD) and Parkinson's disease (PD). This review article presents evidence for nicotinic acetylcholine receptor (nAChR)-mediated protection and the signal transduction involved in this mechanism. The data is based mainly on our studies using rat-cultured primary neurons. Nicotine-induced protection was blocked by an α7 nAChR antagonist, a phosphatidylinositol 3-kinase (PI3K) inhibitor, and an Src inhibitor. Levels of phosphorylated Akt, an effector of PI3K, Bcl-2 and Bcl-x were increased by nicotine administration. From these experimental data, our hypothesis for the mechanism of nAChR-mediated survival signal transduction is that the α7 nAChR stimulates the Src family, which activates PI3K to phosphorylate Akt, which subsequently transmits the signal to up-regulate Bcl-2 and Bcl-x. Up-regulation of Bcl-2 and Bcl-x could prevent cells from neuronal death induced by β-amyloid (Aβ), glutamate and rotenone. These findings suggest that protective therapy with nAChR stimulation could delay the progress of neurodegenerative diseases such as AD and PD.
  • 关键词:nicotine;nicotinic acetylcholine receptor;neuroprotection;Alzheimer's disease;Parkinson's disease;amyotrophic lateral sclerosis
国家哲学社会科学文献中心版权所有